Medicinova Stock Probability of Future Stock Price Finishing Over 1.57

MNOV Stock  USD 2.00  0.05  2.56%   
MediciNova's future price is the expected price of MediciNova instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of MediciNova performance during a given time horizon utilizing its historical volatility. Check out MediciNova Backtesting, MediciNova Valuation, MediciNova Correlation, MediciNova Hype Analysis, MediciNova Volatility, MediciNova History as well as MediciNova Performance.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.
  
Please specify MediciNova's target price for which you would like MediciNova odds to be computed.

MediciNova Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MediciNova for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MediciNova can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MediciNova is way too risky over 90 days horizon
MediciNova appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M.
MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.

MediciNova Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MediciNova Stock often depends not only on the future outlook of the current and potential MediciNova's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MediciNova's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49 M
Cash And Short Term Investments51 M

MediciNova Technical Analysis

MediciNova's future price can be derived by breaking down and analyzing its technical indicators over time. MediciNova Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MediciNova. In general, you should focus on analyzing MediciNova Stock price patterns and their correlations with different microeconomic environments and drivers.

MediciNova Predictive Forecast Models

MediciNova's time-series forecasting models is one of many MediciNova's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MediciNova's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about MediciNova

Checking the ongoing alerts about MediciNova for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MediciNova help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MediciNova is way too risky over 90 days horizon
MediciNova appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M.
MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.